Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Takemoto, Shinya ^a   Shibamoto, Yuta ^a   Ayakawa, Shiho ^b   Nagai, Aiko ^a   Hayashi, Akihiro ^a   Ogino, Hiroyuki ^a   Baba, Fumiya ^a   Yanagi, Takeshi ^a   Sugie, Chikao ^a   Kataoka, Hiromi ^a   Mimura, Mikio ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

IMRT; Late toxicity; Radiation proctitis

Indexed keywords

BETAMETHASONE; DIFLUCORTOLONE; ENEMA; ESCHERICHIA COLI VACCINE; HYDROCORTISONE; LIDOCAINE; NERIPROCT; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; CANCER RADIOTHERAPY; DISEASE SEVERITY; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OINTMENT; PROCTITIS; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; SCORING SYSTEM; SEPTIC SHOCK; SUPPOSITORY; TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROCTITIS; PROGNOSIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 84861993631     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-87     Document Type: Article

References (27)

1. Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology 1985, 9:517-534. 10.1111/j.1365-2559.1985.tb02833.x, 4007790.
2. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol 2006, 22:536-540. 10.1097/01.mog.0000239869.27328.54, 16891886.
3. Sebastian S, O'Connor H, O'Morain C, Buchley M. Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. J Gastrol Hepatol 2004, 19:1169-1173.
4. Kwan V, Bourke MJ, Williams SJ, et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 2006, 101:58-63. 10.1111/j.1572-0241.2006.00370.x, 16405534.
5. Alicikus ZA, Yamada Y, Zhang Z, et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 2011, 117:1429-1437. 10.1002/cncr.25467, 21425143.
6. Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 2009, 93:185-191. 10.1016/j.radonc.2009.09.001, 19800702.
7. De Meerleer GO, Fonteyne VH, Vakaet L, et al. Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control. Radiother Oncol 2007, 82:160-166. 10.1016/j.radonc.2006.12.007, 17222931.
8. Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2011, 80:437-444. 10.1016/j.ijrobp.2010.02.040, 21050673.
9. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1124-1129. 10.1016/j.ijrobp.2007.11.044, 18313526.
10. Ghadjar P, Vock J, Vetterli D, et al. Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking. Radiat Oncol 2008, 3:35. 10.1186/1748-717X-3-35, 2613141, 18937833.
11. Chen L, Paskalev K, Zhu J, et al. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer. Radiother Oncol 2010, 95:198-202. 10.1016/j.radonc.2010.02.023, 20303193.
12. D'Amico A, Whittington R, Malkowicz S, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280:969-974. 10.1001/jama.280.11.969, 9749478.
13. Niemerko A, Goitien M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys 1993, 25:135-145. 10.1016/0360-3016(93)90156-P, 8416870.
14. Charneau J, Bouachour G, Person B, Burtin P, Ronceray J, Boyer J. Severe hemorrhagic radiation proctitis advancing to gradual cessation with hyperbaric oxygen. Dig Dis Sci 1991, 36:373-375. 10.1007/BF01318212, 1995275.
15. Goldner G, Pötter R, Kranz A, et al. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy. Strahlenther Onkol 2011, 187:202-205. 10.1007/s00066-010-2211-5, 21347635.
16. O'Brien PC, Hamilton CS, Denham JW, et al. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58:75-80. 10.1016/S0360-3016(03)01445-7, 14697423.
17. Denton AS, Andreyev HJ, Forbes A, et al. Systematic review for non-surgical interventions for the management of late radiation proctitis. Br J Cancer 2002, 87:134-143. 10.1038/sj.bjc.6600360, 2376119, 12107832.
18. Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis: prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal steroids versus rectal sucralfate. Dig Dis Sci 1991, 36:103-107. 10.1007/BF01300096, 1670631.
19. Gul YA, Prasannan S, Jabar FM, Shaker AR, Moissinac K. Pharmacotherapy for chronic hemorrhagic radiation proctitis. World J Surg 2002, 26:1499-1502. 10.1007/s00268-002-6529-8, 12297939.
20. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late rectal complications after prostate brachytherapy for localized prostate cancer. Cancer 2009, 115:1827-1839. 10.1002/cncr.24223, 19248043.
21. Xu CT, Meng SY, Pan BR. Drug therapy for ulcerative colitis. World J Gastroenterol 2004, 10:2311-2317.
22. Lee DA, Taylor GM, James VH, Walker G. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut 1979, 20:349-355. 10.1136/gut.20.5.349, 1412428, 223947.
23. Takeda K, Ogawa Y, Ariga H, et al. Clinical correlations between treatment with anticoagulants/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer. Anticancer Res 2009, 29:1831-1834.
24. Postgate A, Saunders B, Tjandra J, Vargo J. Argon plasma coagulation in chronic radiation proctitis. Endoscopy 2007, 39:361-365. 10.1055/s-2007-966284, 17427074.
25. Tam W, Moore J, Schoeman M. Treatment of radiation proctitis with argon plasma coagulation. Endoscopy 2000, 32:667-672. 10.1055/s-2000-9020, 10989988.
26. Tjandra J, Sengupta S. Argon plasma coagulation is effective in the treatment of refractory radiation proctitis. Dis Colon Rectum 2001, 44:1759-1765. 10.1007/BF02234451, 11742157.
27. Chino A, Uragami N, Hosaka H, et al. Therapeutic strategy for hemorrhagic radiation proctitis-the optimum condition of argon plasma coagulation (APC) [in Japanese with English abstract]. Nippon Shokakibyo Gakkai Zasshi 2005, 102:1405-1411.